Ingunn Dybedal

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Drug Administration

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Panagiotis Baliakas, Bianca Tesi, Jörg Cammenga, Asbjørg Stray-Pedersen, Kirsi Jahnukainen, Mette Klarskov Andersen, Helena Ågerstam, Maria Creignou, Ingunn Dybedal, Klas Raaschou-Jensen, Kirsten Grønbaek, Outi Kilpivaara, Eva Hellström Lindberg, Ulla Waitiovaara-Kautto
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms. HemaSphere 8 (8) (2024)
Panagiotis Baliakas, Bianca Tesi, Jörg Cammenga, Asbjørg Stray-Pedersen, Kirsi Jahnukainen, Mette Klarskov Andersen, Helena Ågerstam, Maria Creignou, Ingunn Dybedal, Klas Raaschou-Jensen, Kirsten Grønbaek, Outi Kilpivaara, Eva Hellström Lindberg, Ulla Waitiovaara-Kautto
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms. HemaSphere 8 (8) (2024)
Otto Emil Nyquist, Jakob Dalgaard, Signe Spetalen, Synne Torkildsen, Hege Frøen, Eivind Galteland, Ole Klungsøyr, Astrid Bergrem, Camilla Vo, Hjalmar Sørbø, Birgitte Eiken, Hedda Lerdal, Ann-Karin Solvang, Hilde Jensvoll, Tatjana Pandzic, Panagiotis Baliakas, Ingunn Dybedal
Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML. British journal of haematology (2023)
Andreas Reiter, Juliana Schwaab, Daniel J DeAngelo, Jason Gotlib, Michael W Deininger, Kristen M Pettit, Iván Alvarez-Twose, Alessandro Maria Maria Vannucchi, Jens Peter Panse, Uwe Platzbecker, Olivier Hermine, Ingunn Dybedal, Hui-Min Lin, Svetlana N Rylova, Katrin Ehlert, Saša Dimitrijević, Deepti H Radia
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis. Blood advances 6 (21) (2022)